These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37869747)

  • 21. Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation.
    Wyles SP; Tchkonia T; Kirkland JL
    Plast Reconstr Surg; 2022 Oct; 150():20S-26S. PubMed ID: 36170432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic.
    Al-Mansour F; Alraddadi A; He B; Saleh A; Poblocka M; Alzahrani W; Cowley S; Macip S
    Aging (Albany NY); 2023 Mar; 15(7):2373-2394. PubMed ID: 36988504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical strategies and animal models for developing senolytic agents.
    Kirkland JL; Tchkonia T
    Exp Gerontol; 2015 Aug; 68():19-25. PubMed ID: 25446976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling.
    Xu W; Zhao T; Chen H; Huang N; Gong H; Zhang J; Yang Y; Li T; Zhang G; Gong C; Yang M; Xiao H
    Biochem Pharmacol; 2022 Jun; 200():115045. PubMed ID: 35439535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Senolytic drugs: from discovery to translation.
    Kirkland JL; Tchkonia T
    J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
    Roos CM; Zhang B; Palmer AK; Ogrodnik MB; Pirtskhalava T; Thalji NM; Hagler M; Jurk D; Smith LA; Casaclang-Verzosa G; Zhu Y; Schafer MJ; Tchkonia T; Kirkland JL; Miller JD
    Aging Cell; 2016 Oct; 15(5):973-7. PubMed ID: 26864908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle.
    Liu L; Yue X; Sun Z; Hambright WS; Feng Q; Cui Y; Huard J; Robbins PD; Wang Z; Mu X
    Aging (Albany NY); 2022 Sep; 14(19):7650-7661. PubMed ID: 36084954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nintedanib induces senolytic effect via STAT3 inhibition.
    Cho HJ; Hwang JA; Yang EJ; Kim EC; Kim JR; Kim SY; Kim YZ; Park SC; Lee YS
    Cell Death Dis; 2022 Sep; 13(9):760. PubMed ID: 36055997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoinformatic Screening for the Selection of Potential Senolytic Compounds from Natural Products.
    Barrera-Vázquez OS; Gómez-Verjan JC; Magos-Guerrero GA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33809876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs.
    L'Hôte V; Mann C; Thuret JY
    Open Biol; 2022 Sep; 12(9):220171. PubMed ID: 36128715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
    Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
    Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe
    Lewinska A; Adamczyk-Grochala J; Bloniarz D; Olszowka J; Kulpa-Greszta M; Litwinienko G; Tomaszewska A; Wnuk M; Pazik R
    Redox Biol; 2020 Jan; 28():101337. PubMed ID: 31622846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics.
    Okuno K; Cicalese S; Elliott KJ; Kawai T; Hashimoto T; Eguchi S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of senolytic drugs on human mesenchymal stromal cells.
    Grezella C; Fernandez-Rebollo E; Franzen J; Ventura Ferreira MS; Beier F; Wagner W
    Stem Cell Res Ther; 2018 Apr; 9(1):108. PubMed ID: 29669575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for senolytic drug discovery.
    Power H; Valtchev P; Dehghani F; Schindeler A
    Aging Cell; 2023 Oct; 22(10):e13948. PubMed ID: 37548098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of senolytic treatment to prevent cognitive decline in a female rodent model of aging.
    Rani A; Bean L; Budamagunta V; Kumar A; Foster TC
    Front Aging Neurosci; 2024; 16():1384554. PubMed ID: 38813533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
    Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
    Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular senescence in the aging brain: A promising target for neurodegenerative diseases.
    Sahu MR; Rani L; Subba R; Mondal AC
    Mech Ageing Dev; 2022 Jun; 204():111675. PubMed ID: 35430158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
    Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
    Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senescence-mediated anticancer effects of quercetin.
    Özsoy Gökbilen S; Becer E; Vatansever HS
    Nutr Res; 2022 Aug; 104():82-90. PubMed ID: 35635900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.